Saturday 17 October 2026
Export UTMD’s income statement to Excel — free account
Utah Medical Products, Inc.
UTMD Healthcare Medical Instruments & Supplies
Utah Medical Products, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.5 million, down 5.83% from fiscal 2024. In the quarter to June 2026, revenue fell 14.3%, EPS fell 10.6% and free cash flow fell 55.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years.
74.51
0.41
−0.55%
Follow UTMD
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
9 | 6 | 5 | 8 | 6 | 9 | 7 | 6 | 6 | 6 |
P/E ratio |
22.24 | 34.63 | 16.78 | 27.39 | 28.77 | 24.69 | 21.68 | 18.27 | 15.56 | 16.08 |
P/S ratio |
6.82 | 7.12 | 7.38 | 8.56 | 7.31 | 7.43 | 6.80 | 6.03 | 5.26 | 4.71 |
Altman Z-Score |
26.77 | 15.40 | 20.37 | 30.64 | 23.54 | 28.83 | 25.99 | 28.77 | 28.36 | 36.25 |
Altman Z″-Score (non-manufacturers) |
18.07 | 13.10 | 16.86 | 19.65 | 19.59 | 21.52 | 21.31 | 27.94 | 33.27 | 47.39 |
P/FCF ratio |
23.86 | 19.27 | 17.92 | 0.00 | 0.00 | 0.00 | 17.49 | 14.00 | 14.73 | 12.66 |
Beneish M-Score |
(2.83) | (3.00) | (2.37) | (2.23) | (3.08) | (2.59) | (2.85) | (3.06) | (2.12) | (2.68) |
P/Operating CF |
79.12 | 64.30 | 69.13 | 71.17 | 53.37 | 73.13 | 62.60 | 56.82 | 73.32 | 52.15 |
P/B ratio |
3.87 | 3.77 | 3.48 | 3.97 | 3.00 | 3.40 | 3.11 | 2.36 | 1.83 | 1.52 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 82 |
Price to Tangible BV |
7.14 | 6.38 | 5.12 | 7.05 | 4.77 | 4.84 | 3.93 | 2.76 | 2.13 | 1.74 |
EV/Sales |
6.17 | 6.18 | 6.18 | 7.67 | 6.11 | 6.21 | 5.38 | 4.20 | 3.26 | 2.51 |
EV/EBITDA |
12.75 | 11.75 | 12.00 | 14.67 | 12.32 | 11.65 | 10.47 | 9.12 | 8.11 | 6.70 |
EV/Operating CF |
16.69 | 15.13 | 15.43 | 21.09 | 12.80 | 14.37 | 13.31 | 9.47 | 8.99 | 6.57 |
EV/FCF |
21.60 | 16.72 | 15.02 | (80.21) | (149.60) | (873.06) | 13.85 | 9.75 | 9.12 | 6.74 |
Quick Ratio |
9.79 | 8.25 | 10.47 | 13.78 | 14.69 | 17.65 | 13.52 | 20.44 | 23.18 | 34.36 |
Current Ratio |
11.41 | 9.32 | 11.58 | 15.92 | 16.42 | 19.53 | 15.09 | 22.56 | 25.64 | 37.62 |
Net Debt/EBITDA |
(1.39) | (1.83) | (2.36) | (1.75) | (2.47) | (2.33) | (2.79) | (4.01) | (5.05) | (5.95) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.51 | 0.49 | 0.44 | 0.45 | 0.38 | 0.43 | 0.44 | 0.39 | 0.32 | 0.31 |
Operating CF/Net income |
1.20 | 1.99 | 0.91 | 1.16 | 1.86 | 1.43 | 1.28 | 1.34 | 1.07 | 1.30 |
Capex/Depreciation |
(1.17) | (0.58) | 0.16 | (3.13) | (0.12) | (0.08) | (0.12) | (0.10) | (0.07) | (0.12) |
Interest Coverage |
1,348.92 | 1,118.29 | 86.16 | 69.42 | 122.39 | 113.73 | 29.94 | — | — | — |
| 17.46% | 11.54% | 22.21% | 15.50% | 10.59% | 14.09% | 14.88% | 13.72% | 11.29% | 9.54% | |
| 15.61% | 10.07% | 19.28% | 14.06% | 9.75% | 13.01% | 13.76% | 12.83% | 10.76% | 9.21% | |
ROIC |
23.59% | 31.13% | 30.85% | 18.90% | 16.72% | 25.56% | 31.55% | 29.58% | 24.66% | 21.26% |
Return on Tangible Assets |
29.28% | 15.32% | 28.11% | 23.69% | 15.47% | 18.48% | 17.49% | 14.84% | 13.56% | 10.74% |
Average Days of Receivables |
29.82 | 31.93 | 34.38 | 36.90 | 35.52 | 38.19 | 38.66 | 24.64 | 36.53 | 33.37 |
Research and Development Expense of Revenue |
1.21% | 1.08% | 1.08% | 1.03% | 1.15% | 1.07% | 0.94% | 1.12% | 1.99% | 1.73% |
Selling, General and Administrative Expense of Revenue |
17.88% | 16.75% | 17.04% | 24.20% | 26.92% | 23.47% | 22.79% | 25.29% | 23.80% | 25.78% |
Intangible Assets out of Total Assets |
0.42 | 0.34 | 0.29 | 0.40 | 0.34 | 0.28 | 0.19 | 0.14 | 0.13 | 0.12 |
Share Based Compensation of Revenue |
0.23% | 0.31% | 0.15% | 0.24% | 0.38% | 0.34% | 0.35% | 0.45% | 0.63% | 0.97% |
Graham Net Nets |
0.10 | 0.12 | 0.16 | 0.12 | 0.17 | 0.18 | 0.23 | 0.33 | 0.42 | 0.52 |
Graham Number |
36.51 | 32.90 | 51.55 | 49.08 | 43.05 | 51.74 | 56.46 | 60.30 | 54.58 | 53.69 |
Earnings Yield |
4.50% | 2.89% | 5.96% | 3.65% | 3.48% | 4.05% | 4.61% | 5.47% | 6.43% | 6.22% |
Free Cash Flow Yield |
4.19% | 5.19% | 5.58% | (1.12%) | (0.56%) | (0.10%) | 5.72% | 7.14% | 6.79% | 7.90% |
Revenue per Share |
10.48 | 11.14 | 11.26 | 12.61 | 11.53 | 13.45 | 14.37 | 13.84 | 11.68 | 11.89 |
Operating CF per Share |
3.87 | 4.55 | 4.51 | 4.58 | 5.50 | 5.81 | 5.81 | 6.14 | 4.23 | 4.53 |
Capex per Share |
(0.88) | (0.43) | 0.12 | (5.79) | (0.24) | (0.15) | (0.22) | (0.18) | (0.06) | (0.11) |
Free Cash Flow per Share |
2.99 | 4.12 | 4.64 | (1.21) | 5.27 | 5.66 | 5.59 | 5.96 | 4.17 | 4.42 |
Cash per Share |
7.03 | 10.75 | 13.70 | 11.50 | 14.10 | 16.72 | 20.64 | 25.59 | 23.69 | 26.47 |
Shareholders Equity per Share |
18.46 | 21.01 | 23.86 | 27.17 | 28.11 | 29.38 | 31.41 | 35.36 | 33.52 | 36.81 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
18.46 | 21.01 | 23.86 | 27.17 | 28.11 | 29.38 | 31.41 | 35.36 | 33.52 | 36.81 |
Free Cash Flow |
11.23 | 15.31 | 17.29 | (4.48) | 19.28 | 20.65 | 20.33 | 21.64 | 14.62 | 14.32 |
Working Capital |
31.45 | 43.91 | 55.64 | 51.44 | 58.47 | 69.41 | 83.96 | 101.56 | 92.57 | 95.14 |
Capital Expenditures |
(3.30) | (1.60) | 0.46 | (21.54) | (0.86) | (0.55) | (0.82) | (0.64) | (0.21) | (0.37) |
Net Current Asset Value |
27.53 | 34.57 | 50.13 | 46.19 | 53.34 | 64.66 | 80.30 | 99.12 | 91.22 | 94.47 |
EV/EBIT |
14.98 | 13.46 | 13.89 | 20.40 | 18.80 | 16.14 | 14.22 | 12.58 | 9.81 | 8.47 |
Capex to Sales |
0.08 | 0.04 | (0.01) | 0.46 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
16.55 | 15.51 | 16.57 | 22.77 | 22.50 | 19.32 | 17.97 | 18.06 | 15.84 | 15.90 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.28 | 0.24 | 0.29 | 0.64 | 0.64 | 0.69 | 0.69 | 0.60 | 0.29 | 0.30 |
Cash ROIC |
11.74% | 12.97% | 12.34% | (3.12%) | 12.48% | 12.28% | 10.74% | 9.78% | 7.30% | 6.99% |
Accounts Receivable Turnover |
10.11 | 12.12 | 11.08 | 10.79 | 9.54 | 10.62 | 9.80 | 11.25 | 10.93 | 10.12 |
Accounts Payable Turnover |
20.07 | 16.33 | 16.44 | 16.82 | 17.64 | 23.42 | 20.30 | 20.32 | 22.88 | 20.56 |
Inventory Turnover |
3.57 | 3.07 | 2.95 | 2.83 | 2.53 | 2.83 | 2.61 | 2.19 | 1.82 | 1.97 |
Average Days of Payables |
21.19 | 22.70 | 22.68 | 22.98 | 17.30 | 15.31 | 22.13 | 13.90 | 15.16 | 20.13 |
Days of Inventory on Hand |
106.22 | 127.44 | 125.88 | 144.72 | 136.56 | 132.74 | 160.17 | 173.26 | 191.91 | 175.33 |
Average Receivables |
3.89 | 3.42 | 3.79 | 4.35 | 4.42 | 4.62 | 5.34 | 4.46 | 3.74 | 3.81 |
Average Payables |
0.78 | 0.92 | 0.95 | 1.04 | 0.94 | 0.77 | 0.99 | 0.99 | 0.73 | 0.80 |
Average Inventory |
4.37 | 4.89 | 5.33 | 6.16 | 6.57 | 6.41 | 7.71 | 9.20 | 9.20 | 8.37 |
Average Assets |
77.68 | 84.47 | 96.26 | 104.78 | 110.77 | 113.69 | 119.76 | 129.67 | 129.00 | 122.54 |
Average Common Equity |
69.45 | 73.68 | 83.56 | 95.04 | 101.96 | 104.98 | 110.70 | 121.28 | 122.87 | 118.35 |
Columns are period end dates